Research
And Grants
Note: When clicking the "Submit Grant Application" button below you will be redirected to SnapGrant.com to complete the application process.
Submit Grant ApplicationThe Cure Starts Now has funded $25,084,877 (USD) in pediatric brain cancer research in partnership with the DIPG / DMG Collaborative. This includes 163 grants at over 100 hospitals in 29 countries.
The Hospital for Sick Children - $100,560
$100,560.00
October 2017
MRI Guided Focused Ultrasound: Towards Clinical Translation in Diffuse Intrinsic Pontine Glioma (DIPG)
Texas Children's Hospital and Ann & Robert H. Lurie Children's Hospital of Chicago - $200,000
$200,000.00
October 2017
Targeting DIPG through Combining a Super-activator (MCB-613) of Steroid Receptor Co-activators with Radiation.
Gustave Roussy - $101,868
$101,868.00
October 2017
Elucidating the underlying mechanisms of radio resistance at diagnosis and relapse in DIPG
Ospedale Pediatrico Bambino Gesu - $98,987
$98,987.00
October 2017
Investigating the role of DIPG-derived exosomes in tumor growth and invasion
Memorial Sloan Kettering Cancer Center - $100,000
$100,000.00
October 2017
Targeting EZH2 as a therapeutic strategy in DIPG
Dana-Farber Cancer Institute - $82,863
$82,863.00
October 2017
Defining the Cellular Architecture of Diffuse Intrinsic Pontine Glioma through Large-Scale Single-cell RNA-sequencing analyses
The Hospital of Sick Children - $162,828
$162,828.00
October 2017
Targeting DIPG through pharmacological activation of mitochondrial biogenesis: an in vitro and in vivo preclinical study
Stanford University - $200,000
$200,000.00
October 2017
Targeting neuronal activity regulated DIPG infiltration
Children's Cancer Institute (AU) - $185,706
$185,706.00
October 2017
Developing novel combination therapeutic approaches for DIPG targeting Polo-like Kinase 1
Children's National Medical Center - $200,000
$200,000.00
October 2017
Validation of TAK228 as an effective drug for treating children with DIPG
Ann & Robert H. Lurie Children's Hospital - $100,000
$100,000.00
October 2017
Determine the efficacy of BMP and MEK inhibitors with RT to treat ACVR1 mutant DIPG
Anschutz Medical Campus - $50,000
$50,000.00
September 2017
Toward a Multimodality Cure for DIPG: Investigation of Intratumoral Drug Penetration and Craniospinal Irradiation.
Massachusetts General Hospital - $50,000
$50,000.00
September 2017
Repurposing Mefloquine for Diffuse Intrinsic Pontine Glioma Therapy
CONNECT Consortium - $893,678.37
$893,678.00
September 2017
CONNECT (COllaborative Network for NEurooncology Clinical Trials) Consortium
University of Massachusetts Medical School - $50,000
$50,000.00
May 2017
Advanced RNAi therapeutics for DIPG